Article
Alterations of plasma exosomal proteins and motabolies are associated with the progression of castration-resistant prostate cancer
2022-11-09
Abstract excerpt
<title>Abstract</title> <p><bold>Background</bold>: Current diagnosis tools for prostate cancer (PCa) such as serum PSA detection and prostate biopsy cannot distinguish dormant tumors from invasive malignancies, either be used as prognosis marker for castration resistant prostate cancer (CRPC), the lethal stage of PCa patients. Exosomes have been widely investigated as promising biomarkers for various diseases. W...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a4f775ad-519f-57df-b1d5-c633a108e077
- DOI
- 10.21203/rs.3.rs-2130334/v1
